carbidopa has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamski, P; Alexopoulos, D; Badarienė, J; Budaj, A; Buszko, K; Dąbrowski, P; Di Somma, S; Dudek, D; Gąsior, M; Giannitsis, E; Gil, R; Gorog, DA; Gruchała, M; Gurbel, PA; Horszczaruk, G; Jaguszewski, MJ; James, S; Jeong, YH; Jilma, B; Kasprzak, J; Kleinrok, A; Kryjak, M; Kubica, A; Kubica, J; Legutko, J; Lesiak, M; Navarese, EP; Niezgoda, P; Ostrowska, M; Patti, G; Romanek, J; Siller-Matula, JM; Specchia, G; Tantry, U; Tycińska, A; Wojakowski, W | 1 |
| Adamski, P; Buszko, K; Gasior, M; Gorący, J; Kleinrok, A; Kosobucka, A; Kubica, A; Kubica, J; Lesiak, M; Nadolny, K; Navarese, E; Niezgoda, P; Wojakowski, W | 1 |
1 trial(s) available for carbidopa and Acute Coronary Syndrome
| Article | Year |
|---|---|
ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial.
Topics: Acute Coronary Syndrome; Analgesics; Carbidopa; Drug Combinations; Humans; Levodopa; Methoxyflurane; Morphine; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Treatment Outcome | 2021 |
1 other study(ies) available for carbidopa and Acute Coronary Syndrome
| Article | Year |
|---|---|
Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial.
Topics: Acute Coronary Syndrome; Aspirin; Carbidopa; Drug Combinations; Humans; Levodopa; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome | 2022 |